Range Low Price High Price Comment
30 days $31.23 $31.23 Wednesday, 1st May 2024 IMGN stock ended at $31.23. During the day the stock fluctuated 0% from a day low at $31.23 to a day high of $31.23.
90 days $29.21 $31.25
52 weeks $10.31 $31.25

Historical ImmunoGen prices

Date Open High Low Close Volume
Jul 17, 2023 $19.53 $19.99 $19.28 $19.47 4 151 987
Jul 14, 2023 $18.92 $19.60 $18.76 $19.50 4 806 753
Jul 13, 2023 $18.73 $19.00 $18.51 $18.82 1 702 859
Jul 12, 2023 $18.89 $19.25 $18.62 $18.72 2 196 975
Jul 11, 2023 $18.59 $18.79 $18.27 $18.69 2 103 235
Jul 10, 2023 $18.41 $18.81 $18.37 $18.79 2 345 414
Jul 07, 2023 $18.64 $18.98 $17.91 $18.36 3 441 901
Jul 06, 2023 $18.55 $18.66 $18.27 $18.54 1 897 085
Jul 05, 2023 $18.73 $19.17 $18.55 $18.66 2 273 342
Jul 03, 2023 $18.81 $19.00 $18.50 $18.83 1 330 982
Jun 30, 2023 $18.85 $19.25 $18.80 $18.87 3 402 500
Jun 29, 2023 $18.86 $18.96 $18.47 $18.79 4 142 706
Jun 28, 2023 $19.08 $19.77 $18.84 $18.89 3 945 930
Jun 27, 2023 $19.03 $19.52 $18.73 $19.08 3 631 426
Jun 26, 2023 $20.00 $20.10 $18.89 $18.92 4 875 826
Jun 23, 2023 $19.55 $20.28 $19.48 $20.05 6 587 524
Jun 22, 2023 $18.98 $19.98 $18.83 $19.75 5 468 903
Jun 21, 2023 $18.90 $19.46 $18.50 $19.21 6 006 952
Jun 20, 2023 $18.51 $19.71 $18.47 $19.09 8 471 796
Jun 16, 2023 $18.98 $19.24 $18.32 $18.44 22 266 679
Jun 15, 2023 $18.55 $18.93 $18.03 $18.70 8 893 254
Jun 14, 2023 $17.94 $18.27 $17.42 $17.72 6 278 196
Jun 13, 2023 $18.00 $18.45 $17.65 $17.89 5 891 045
Jun 12, 2023 $17.29 $18.21 $16.89 $17.81 7 250 902
Jun 09, 2023 $16.60 $17.34 $16.30 $17.16 11 898 613
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT